IL-1 in Abdominal Aortic Aneurysms
- PMID: 37476160
- PMCID: PMC10357974
- DOI: 10.33696/immunology.5.163
IL-1 in Abdominal Aortic Aneurysms
Abstract
Abdominal Aortic Aneurysms (AAA) remain a clinically devastating disease with no effective medical treatment therapy. AAAs are characterized by immune cell infiltration, smooth muscle cell apoptosis, and extracellular matrix degradation. Interleukin-1 (IL-1) has been shown to play role in AAA associated inflammation through immune cell recruitment and activation, endothelial dysfunction, production of reactive oxygen species (ROS), and regulation of transcription factors of additional inflammatory mediators. In this review, we will discuss the principles of IL-1 signaling, its role in AAA specific inflammation, and regulators of IL-1 signaling. Additionally, we will discuss the influence of genetic and pharmacological inhibitors of IL-1 on experimental AAAs. Evidence suggests that IL-1 may prove to be a potential therapeutic target in the management of AAA disease.
Keywords: AAA; Anakinra; IL-1α; IL-1β.
Figures
References
-
- Kent KC. Abdominal aortic aneurysms. New England Journal of Medicine. 2014. Nov 27;371(22):2101–8. - PubMed
-
- Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, et al. Analysis of Risk Factors for Abdominal Aortic Aneurysm in a Cohort of more than 3 million individuals. Journal of Vascular Surgery. 52:539–548. - PubMed
-
- Thompson RW, Geraghty PJ, Lee JK. Abdominal Aortic Aneurysms: Basic Mechanisms and Clinical Implications. Current Problems in Surgery. 2002. Feb 1;39(2):110–230. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources